EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Identification of Hepatic-like EPO as a Cause of Polycythemia

Laurent Martin, Darko Maric, Salam Idriss, Marine Delamare, Amandine Le Roy, Nada Maaziz, Amandine Caillaud, Karim Si-Tayeb, Florence Robriquet, Marion Lenglet, Lucie Erceau, Christine Bellanné-Chantelot und 45 weitere

New England Journal of Medicine · 2025

DOI: 10.1056/nejmoa2414954 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift New England Journal of Medicine, 2025. Verfasst von Laurent Martin und 56 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Antidopage Français, Université Paris-Saclay, Orsay, France. Hauptthemen laut MEDLINE: Erythropoietin, Polycythemia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: European Regional Development Fund, Agence Nationale de la Recherche, H2020 Marie Skłodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Secondary erythrocytosis often results from conditions that cause tissue hypoxia or an improper increase in erythropoietin (EPO) production. EPO, the major regulator of erythropoiesis, has a complex and tightly regulated expression during development, with a liver-to-kidney switch shortly after birth.

Methods

We identified six families with erythrocytosis that was associated with circulating EPO levels within the normal range and characterized as a novel molecular and functional entity. We investigated the effect of the identified pathogenic variants using EPO promoter–driven luciferase reporter genes. Induced pluripotent stem cells (iPSCs) were generated from patient cells and differentiated into hepatocyte-like EPO-producing cells. Samples of circulating EPO from patients with hereditary erythrocytosis and from healthy newborns were analyzed by means of isoelectric focusing, and EPO activity was assessed.

Results

Three novel variants were identified in the noncoding regions of EPO . Experiments with reporter assays and iPSC-derived hepatocyte-like cells showed that the variants targeted previously uncharacterized regulatory elements of the gene, which, when the variants were present, showed high responsiveness to hypoxia. EPO samples from all the patients showed a modified isoelectric-focusing profile, identical to hepatic EPO that is expressed in premature neonates and in patients with acquired erythrocytosis associated with liver diseases. EPO that was purified from patient plasma and umbilical-cord blood samples showed enhanced EPO receptor signaling activity in vitro, which suggests a potential gain of function linked to the liver-type glycosylation of EPO.

Conclusions

We found that secondary erythrocytosis can be related to variants in EPO that lead to the production of hepatic-like EPO with an atypical glycosylation pattern and increased activity. (Funded by Région des Pays de la Loire and others; ClinicalTrials.gov number, NCT03957863 .)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythropoietinPolycythemiaAdultFemaleHumansMaleHepatocytesInduced Pluripotent Stem CellsLiverMutationPedigreeHEK293 CellsCell Line, TumorChildAdolescentYoung AdultMiddle AgedAgedHigh-Throughput Nucleotide SequencingMutagenesis, Site-DirectedGlycosylation

Substanzen

EPO protein, humanErythropoietin

Autor:innen und Institutionen

  • Laboratoire Antidopage Français, Université Paris-Saclay, Orsay, France.
  • Section of Medicine, Department of Endocrinology, Metabolism, and Cardiovascular System, University of Fribourg, Fribourg, Switzerland.
  • National Center of Competence in Research Kidney Control of Homeostasis (Kidney.CH), Fribourg, Switzerland.
  • École Pratique des Hautes Études, Paris Sciences et Lettres Université, Paris.
  • Nantes Université, Centre Hospitalier Universitaire (CHU) Nantes, Centre National de la Recherche Scientifique (CNRS), INSERM, l'Institut du Thorax, Nantes, France.
  • Service d'Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France.

ORCID-Profile: Isabelle Plo

Förderung

  • European Regional Development Fund
  • Agence Nationale de la Recherche
  • H2020 Marie Skłodowska-Curie Actions
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Swiss National Centre of Competence in Research Kidney Control of Homeostasis
  • FEDER
  • VHL Alliance USA
  • Swiss National Science Foundation project

Zitieren

APA

Martin, L., Maric, D., Idriss, S., Delamare, M., Le Roy, A., Maaziz, N., Caillaud, A., Si-Tayeb, K., Robriquet, F., Lenglet, M., Erceau, L., Bellanné-Chantelot, C., Plo, I., Aral, B., Garrec, C., Airaud, F., Gianfermi, C., Antunes, V., Keppner, A., …, & Gardie, B. (2025). Identification of Hepatic-like EPO as a Cause of Polycythemia. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2414954

Vancouver

Martin L, Maric D, Idriss S, Delamare M, Le Roy A, Maaziz N, et al. Identification of Hepatic-like EPO as a Cause of Polycythemia. New England Journal of Medicine. 2025. doi:10.1056/nejmoa2414954

BibTeX
@article{Martin2025,
  author = {Martin, Laurent and Maric, Darko and Idriss, Salam and Delamare, Marine and Le Roy, Amandine and Maaziz, Nada and Caillaud, Amandine and Si-Tayeb, Karim and Robriquet, Florence and Lenglet, Marion and Erceau, Lucie and Bellanné-Chantelot, Christine and Plo, Isabelle and Aral, Bernard and Garrec, Céline and Airaud, Fabrice and Gianfermi, Clara and Antunes, Vincent and Keppner, Anna and Vincent, Sarah Mathilda and Desfontaine, Alexis and Modé, Nina and Laporte, Fabien and Gaignerie, Anne and Chariau, Caroline and Leray, Isabelle and Rogue, Coline and David, Laurent and Redon, Richard and Bézieau, Stéphane and Mansour-Hendili, Lamisse and Galactéros, Frédéric and Maillet, Thibault and Pasquet, Marlène and Cougoul, Pierre and Nloga, Anne-Marie and Gardin, Claude and Guitton, Corinne and Dubruille, Viviane and Giacobbi-Milet, Vannina and Leblanc, Thierry and Kaya, Zuhre and Semama, Denis and James, Chloé and Carillo, Serge and Ochmann, Marlène and Waage, Anders and Mortier, Erwan and Maillasson, Mike and Quéméner, Agnès and Cario, Holger and Skoda, Radek C and Zermati, Yaël and Hoogewijs, David and Marchand, Alexandre and Girodon, François and Gardie, Betty},
  title = {Identification of Hepatic-like EPO as a Cause of Polycythemia},
  journal = {New England Journal of Medicine},
  year = {2025},
  doi = {10.1056/nejmoa2414954}
}
Kostenlos starten →